AGGRESCAN: a server for the prediction and evaluation of "hot spots" of aggregation in polypeptides
暂无分享,去创建一个
Francesc X. Avilés | Oscar Conchillo-Solé | Xavier Daura | Josep Vendrell | Salvador Ventura | Natalia S. de Groot
[1] C. Dobson,et al. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases , 2002, Nature.
[2] T. Iwatsubo,et al. Biochemical characterization of the core structure of alpha-synuclein filaments. , 2002, The Journal of biological chemistry.
[3] V. Turk,et al. In vitro study of stability and amyloid‐fibril formation of two mutants of human stefin B (cystatin B) occurring in patients with EPM1 , 2005, Protein Science.
[4] Robert G Griffin,et al. Molecular conformation of a peptide fragment of transthyretin in an amyloid fibril , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[5] K. Kovacs,et al. Characterization of spherical amyloid protein from a prolactin-producing pituitary adenoma , 1996, Acta Neuropathologica.
[6] Yuji Goto,et al. Amyloidogenic synthetic peptides of beta2-microglobulin--a role of the disulfide bond. , 2003, Biochemical and biophysical research communications.
[7] Meital Reches,et al. Amyloidogenic hexapeptide fragment of medin: homology to functional islet amyloid polypeptide fragments , 2004, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[8] Angelo Fontana,et al. A highly amyloidogenic region of hen lysozyme. , 2004, Journal of molecular biology.
[9] M. Nagao,et al. Analysis of the Secondary Structure of β-Amyloid (Aβ42) Fibrils by Systematic Proline Replacement* , 2004, Journal of Biological Chemistry.
[10] Michel Goedert,et al. Alpha-synuclein and neurodegenerative diseases , 2001, Nature Reviews Neuroscience.
[11] P. Fraser,et al. Identification of minimal peptide sequences in the (8-20) domain of human islet amyloid polypeptide involved in fibrillogenesis. , 2003, Journal of structural biology.
[12] P. Lansbury,et al. Amyloid fibrillogenesis: themes and variations. , 2000, Current opinion in structural biology.
[13] Fabrizio Chiti,et al. Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[14] Christine Wurth,et al. Mutations that reduce aggregation of the Alzheimer's Abeta42 peptide: an unbiased search for the sequence determinants of Abeta amyloidogenesis. , 2002, Journal of molecular biology.
[15] Huilin Li,et al. Structural Role of Glycine in Amyloid Fibrils Formed from Transmembrane α-Helices† , 2005 .
[16] C. Dobson,et al. Rationalization of the effects of mutations on peptide andprotein aggregation rates , 2003, Nature.
[17] J. Liepnieks,et al. Variant apolipoprotein AI as a major constituent of a human hereditary amyloid. , 1988, Biochemical and biophysical research communications.
[18] Ronald Wetzel,et al. Kinetic analysis of beta-amyloid fibril elongation. , 2004, Analytical biochemistry.
[19] R. Berry,et al. Tau polymerization: role of the amino terminus. , 2003, Biochemistry.
[20] M. Baumann,et al. Amphoterin includes a sequence motif which is homologous to the Alzheimer's beta-amyloid peptide (Abeta), forms amyloid fibrils in vitro, and binds avidly to Abeta. , 2001, Biochemistry.
[21] E. Mandelkow,et al. Structure, microtubule interactions, and paired helical filament aggregation by tau mutants of frontotemporal dementias. , 2000, Biochemistry.
[22] L. Tjernberg,et al. Proteolytic generation and aggregation of peptides from transmembrane regions: lung surfactant protein C and amyloid β-peptide , 2004, Cellular and Molecular Life Sciences CMLS.
[23] 宁北芳,et al. 疟原虫var基因转换速率变化导致抗原变异[英]/Paul H, Robert P, Christodoulou Z, et al//Proc Natl Acad Sci U S A , 2005 .
[24] C. Betsholtz,et al. Islet amyloid polypeptide — a novel controversy in diabetes research , 1992, Diabetologia.
[25] D. Brems,et al. Inverse Relationship of Protein Concentration and Aggregation , 2002, Pharmaceutical Research.
[26] L. Serrano,et al. A comparative study of the relationship between protein structure and beta-aggregation in globular and intrinsically disordered proteins. , 2004, Journal of molecular biology.
[27] E. Mandelkow,et al. Structure, Stability, and Aggregation of Paired Helical Filaments from Tau Protein and FTDP-17 Mutants Probed by Tryptophan Scanning Mutagenesis* , 2002, The Journal of Biological Chemistry.
[28] Amedeo Caflisch,et al. Prediction of aggregation rate and aggregation‐prone segments in polypeptide sequences , 2005, Protein science : a publication of the Protein Society.
[29] A. Fink. Protein aggregation: folding aggregates, inclusion bodies and amyloid. , 1998, Folding & design.
[30] L. Serrano,et al. Insights into the origin of the tendency of the PI3-SH3 domain to form amyloid fibrils. , 2002, Journal of molecular biology.
[31] J. Liepnieks,et al. Renal amyloidosis with a frame shift mutation in fibrinogen aalpha-chain gene producing a novel amyloid protein. , 1997, Blood.
[32] Susan Jones,et al. Amyloid-forming peptides from beta2-microglobulin-Insights into the mechanism of fibril formation in vitro. , 2003, Journal of molecular biology.
[33] Thorsten Lührs,et al. Correlation of structural elements and infectivity of the HET-s prion , 2005, Nature.
[34] C. Dobson,et al. High-resolution molecular structure of a peptide in an amyloid fibril determined by magic angle spinning NMR spectroscopy. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[35] G. Forloni,et al. Molecular determinants of the physicochemical properties of a critical prion protein region comprising residues 106-126. , 1999, The Biochemical journal.
[36] David Eisenberg,et al. Structural models of amyloid-like fibrils. , 2006, Advances in protein chemistry.
[37] S. Kahn,et al. Hyperproinsulinemia and Amyloid in NIDDM: Clues to Etiology of Islet β-Cell Dysfunction? , 1989, Diabetes.
[38] Brigida Bochicchio,et al. Supramolecular Amyloid-like Assembly of the Polypeptide Sequence Coded by Exon 30 of Human Tropoelastin* , 2005, Journal of Biological Chemistry.
[39] Ueli Aebi,et al. The parallel superpleated beta-structure as a model for amyloid fibrils of human amylin. , 2005, Journal of molecular biology.
[40] A. Villaverde,et al. Protein quality in bacterial inclusion bodies. , 2006, Trends in biotechnology.
[41] C. Dobson,et al. Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution , 2003, Journal of Molecular Medicine.
[42] D. Baker,et al. The 3D profile method for identifying fibril-forming segments of proteins. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[43] C. Dobson,et al. Protein misfolding, functional amyloid, and human disease. , 2006, Annual review of biochemistry.
[44] Christopher M. Dobson,et al. Protein-misfolding diseases: Getting out of shape , 2002, Nature.
[45] Ralf Langen,et al. Template-assisted filament growth by parallel stacking of tau. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[46] Naoki Yamamoto,et al. Environment‐ and mutation‐dependent aggregation behavior of Alzheimer amyloid β‐protein , 2004, Journal of neurochemistry.
[47] Ehud Gazit,et al. Analysis of the Minimal Amyloid-forming Fragment of the Islet Amyloid Polypeptide , 2001, The Journal of Biological Chemistry.
[48] J. Wade,et al. A structural core within apolipoprotein C-II amyloid fibrils identified using hydrogen exchange and proteolysis. , 2007, Journal of molecular biology.
[49] B. Austen,et al. Non-fibrillar oligomeric species of the amyloid ABri peptide, implicated in familial British dementia, are more potent at inducing apoptotic cell death than protofibrils or mature fibrils. , 2001, Journal of Molecular Biology.
[50] David Eisenberg,et al. A systematic screen of beta(2)-microglobulin and insulin for amyloid-like segments. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[51] L. Serpell,et al. Mutation E46K increases phospholipid binding and assembly into filaments of human alpha-synuclein. , 2004, FEBS letters.
[52] D. Selkoe,et al. Cell biology of protein misfolding: The examples of Alzheimer's and Parkinson's diseases , 2004, Nature Cell Biology.
[53] Adam Smith. Protein misfolding , 2003, Nature.
[54] C M Dobson,et al. Formation and seeding of amyloid fibrils from wild-type hen lysozyme and a peptide fragment from the beta-domain. , 2000, Journal of molecular biology.
[55] R. Nussinov,et al. Hot regions in protein--protein interactions: the organization and contribution of structurally conserved hot spot residues. , 2005, Journal of molecular biology.
[56] Ying Xu,et al. Mapping abeta amyloid fibril secondary structure using scanning proline mutagenesis. , 2004, Journal of molecular biology.
[57] Salvador Ventura,et al. Prediction of "hot spots" of aggregation in disease-linked polypeptides , 2005, BMC Structural Biology.
[58] Susan Idicula-Thomas,et al. Understanding the relationship between the primary structure of proteins and their amyloidogenic propensity: clues from inclusion body formation. , 2005, Protein engineering, design & selection : PEDS.
[59] W. Kamphorst,et al. A novel tau mutation, S320F, causes a tauopathy with inclusions similar to those in Pick's disease , 2002, Annals of neurology.
[60] E. Yılmaz,et al. Genetic Risk Factors of Amyloidogenesis in Familial Mediterranean Fever , 2005, American Journal of Nephrology.
[61] R. Berry,et al. Caspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer's disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[62] S. Greenberg,et al. Pathogenic effects of D23N Iowa mutant amyloid beta -protein. , 2001, The Journal of biological chemistry.
[63] C M Dobson,et al. Designing conditions for in vitro formation of amyloid protofilaments and fibrils. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[64] A. Villaverde,et al. Protein aggregation in recombinant bacteria: biological role of inclusion bodies , 2003, Biotechnology Letters.
[65] Andreas Hoenger,et al. De novo designed peptide-based amyloid fibrils , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[66] David Eisenberg,et al. A systematic screen of β2-microglobulin and insulin for amyloid-like segments , 2006 .
[67] Michele Vendruscolo,et al. Prediction of the absolute aggregation rates of amyloidogenic polypeptide chains. , 2004, Journal of molecular biology.
[68] R. Leapman,et al. A structural model for Alzheimer's β-amyloid fibrils based on experimental constraints from solid state NMR , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[69] K. Tomoo,et al. Aggregation analysis of the microtubule binding domain in tau protein by spectroscopic methods. , 2003, Journal of biochemistry.
[70] Fred E. Cohen,et al. Therapeutic approaches to protein-misfolding diseases , 2003, Nature.
[71] M. Nagao,et al. Analysis of the secondary structure of beta-amyloid (Abeta42) fibrils by systematic proline replacement. , 2004, The Journal of biological chemistry.
[72] Salvador Ventura,et al. Mutagenesis of the central hydrophobic cluster in Abeta42 Alzheimer's peptide. Side-chain properties correlate with aggregation propensities. , 2006, The FEBS journal.
[73] B. Ghetti,et al. Synthetic peptides homologous to prion protein residues 106-147 form amyloid-like fibrils in vitro. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[74] Michele Vendruscolo,et al. Prediction of "aggregation-prone" and "aggregation-susceptible" regions in proteins associated with neurodegenerative diseases. , 2005, Journal of molecular biology.
[75] P. Lansbury,et al. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. , 1993, Biochemistry.
[76] T. Sanke,et al. Missense Mutation of Amylin Gene (S20G) in Japanese NIDDM Patients , 1996, Diabetes.
[77] R. Norton,et al. The Val-210-Ile pathogenic Creutzfeldt-Jakob disease mutation increases both the helical and aggregation propensities of a sequence corresponding to helix-3 of PrP(C). , 2001, Biochimica et biophysica acta.
[78] Bertrand Morel,et al. A single mutation induces amyloid aggregation in the alpha-spectrin SH3 domain: analysis of the early stages of fibril formation. , 2006, Journal of molecular biology.
[79] Christopher M Dobson,et al. Myoglobin forms amyloid fibrils by association of unfolded polypeptide segments , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[80] Michel Goedert,et al. Mutation E46K increases phospholipid binding and assembly into filaments of human α‐synuclein , 2004 .
[81] D. Craik,et al. 1H NMR analysis of fibril-forming peptide fragments of transthyretin. , 2009, International journal of peptide and protein research.
[82] Barry M Wise,et al. Prediction of nucleating sequences from amyloidogenic propensities of tau-related peptides. , 2006, Biochemistry.
[83] Christopher M. Dobson,et al. The protofilament structure of insulin amyloid fibrils , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[84] S. Prusiner,et al. Solid-state NMR structural studies of the fibril form of a mutant mouse prion peptide PrP89-143(P101L). , 2006, Solid state nuclear magnetic resonance.
[85] J. McLaurin,et al. Biophysical characterization of longer forms of amyloid beta peptides: possible contribution to flocculent plaque formation , 2005, Journal of neurochemistry.
[86] Huilin Li,et al. Structural role of glycine in amyloid fibrils formed from transmembrane alpha-helices. , 2005, Biochemistry.
[87] P. Westermark,et al. The N-terminal segment of protein AA determines its fibrillogenic property. , 1992, Biochemical and biophysical research communications.
[88] Salvador Ventura,et al. Short amino acid stretches can mediate amyloid formation in globular proteins: the Src homology 3 (SH3) case. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[89] T. Clackson,et al. A hot spot of binding energy in a hormone-receptor interface , 1995, Science.
[90] H. Vinters,et al. Point substitution in the central hydrophobic cluster of a human beta-amyloid congener disrupts peptide folding and abolishes plaque competence. , 1996, Biochemistry.
[91] K. Iwata,et al. 3D structure of amyloid protofilaments of β2-microglobulin fragment probed by solid-state NMR , 2006, Proceedings of the National Academy of Sciences.
[92] U. Aebi,et al. Full-length rat amylin forms fibrils following substitution of single residues from human amylin. , 2003, Journal of molecular biology.
[93] C. Dobson,et al. Rational design of aggregation-resistant bioactive peptides: reengineering human calcitonin. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[94] J Q Trojanowski,et al. A Hydrophobic Stretch of 12 Amino Acid Residues in the Middle of α-Synuclein Is Essential for Filament Assembly* , 2001, The Journal of Biological Chemistry.
[95] Michail Yu. Lobanov,et al. Prediction of Amyloidogenic and Disordered Regions in Protein Chains , 2006, PLoS Comput. Biol..
[96] G. Irvine,et al. Identification of the region of non‐Aβ component (NAC) of Alzheimer's disease amyloid responsible for its aggregation and toxicity , 2001, Journal of neurochemistry.
[97] H. Vinters,et al. Point Substitution in the Central Hydrophobic Cluster of a Human β-Amyloid Congener Disrupts Peptide Folding and Abolishes Plaque Competence† , 1996 .
[98] Elena Orlova,et al. Cryo‐electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing , 1999, The EMBO journal.
[99] S. Greenberg,et al. Pathogenic Effects of D23N Iowa Mutant Amyloid β-Protein* , 2001, The Journal of Biological Chemistry.
[100] L. Serrano,et al. Protein aggregation and amyloidosis: confusion of the kinds? , 2006, Current opinion in structural biology.
[101] David Eisenberg,et al. An amyloid-forming segment of beta2-microglobulin suggests a molecular model for the fibril. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[102] L. Serrano,et al. Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins , 2004, Nature Biotechnology.
[103] E. Mandelkow,et al. Toward a unified scheme for the aggregation of tau into Alzheimer paired helical filaments. , 2002, Biochemistry.
[104] T. Iwatsubo,et al. Biochemical Characterization of the Core Structure of α-Synuclein Filaments* , 2002, The Journal of Biological Chemistry.